3-(2-Methoxyphenyl)-1-{4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}propan-1-one

Catalog No. :
ACSVWR870
CAS No. :
1775496-05-3
Molecular Formula :
C24H27N3O3
Molecular Weight :
405.50

IUPAC Name:3-(2-methoxyphenyl)-1-(4-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)piperidin-1-yl)propan-1-one

3-(2-Methoxyphenyl)-1-{4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}propan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$120.00Login to see priceInquiryInquiry
10mg95%$147.00Login to see priceInquiryInquiry
50mg95%$207.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2-Methoxyphenyl)-1-{4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}propan-1-one
IUPAC Name3-(2-methoxyphenyl)-1-(4-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)piperidin-1-yl)propan-1-one
MDL No.MFCD28805906
Molecular FormulaC24H27N3O3
Molecular Weight405.50
SMILESO=C(N1CCC(CC2=NC(C3=CC=CC=C3)=NO2)CC1)CCC4=CC=CC=C4OC
InChI KeyNMTSMPWWJZHHQD-UHFFFAOYSA-N
Synonym3-(2-methoxyphenyl)-1-{4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}propan-1-one;1-Propanone, 3-(2-methoxyphenyl)-1-[4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-1-piperidinyl]-
CAS No.1775496-05-3

Synthetic Route by SureRoute

1. ACSVWR870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWDSE940 route compound structure diagram
    ACWDSE9406342-77-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSVWR870 route product structure diagram
    ACSVWR8701775496-05-3
Inquiry

2. ACSVWR870 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSVWR870 route product structure diagram
    ACSVWR8701775496-05-3
Inquiry

Comments (0)